Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Pulmonology Stories

2013-09-26 08:26:53

MOUNTAIN VIEW, Calif., Sept. 26, 2013 /PRNewswire/ -- PneumRx, Inc., a leader in interventional pulmonology, announced that over 1500 procedures have been performed using the RePneu Lung Volume Reduction Coil (LVRC) System for patients with severe emphysema. (Logo: http://photos.prnewswire.com/prnh/20120514/SF06703LOGO) The RePneu LVRC is a minimally invasive device intended to improve lung function, exercise capacity and quality of life in emphysema patients by bronchoscopically...

2013-09-25 23:35:56

Avail is conducting a 24-week study to evaluate the effect of a once-daily experimental inhalation therapy on arterial stiffness compared to a placebo and another drug in subjects with Chronic Obstructive Pulmonary Disease (COPD). DeLand, Florida (PRWEB) September 25, 2013 *To see if you qualify for this COPD Clinical Trial in Florida, visit Avail Clinical Research on the web (http://www.availclinical.com) or contact us directly at (386) 785-2404. There is no cost to participate, no...

2013-09-24 12:28:28

NEW YORK, Sept. 24, 2013 /PRNewswire/ -- In support of Pulmonary Fibrosis Awareness Month, Boehringer Ingelheim and the Coalition for Pulmonary Fibrosis (CPF) are teaming up to raise awareness of idiopathic pulmonary fibrosis, or IPF, a progressive and fatal disease that causes permanent scarring of the lungs, difficulty breathing, and prevents oxygen from getting to the body. This collaboration also features actress Rose McGowan, who is best known for her leading role in the hit...

2013-09-24 08:31:11

BRISBANE, Calif., Sept. 24, 2013 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today announced that Andrew Powell has joined InterMune as Executive Vice President, General Counsel and Corporate Secretary. (Logo: http://photos.prnewswire.com/prnh/20120827/SF62570LOGO) Mr. Powell will be responsible for managing the company's legal affairs. He will report to Dan Welch, Chairman, Chief Executive Officer and President of InterMune. Mr. Welch said, "Andrew brings experience in many...

2013-09-23 08:22:41

-- Adempas® (riociguat) offers new hope for patients suffering from chronic thromboembolic pulmonary hypertension (CTEPH) -- Adempas® is now available in Canada as the first and only drug indicated to manage the treatment of chronic thromboembolic pulmonary hypertension (CTEPH)1,2 TORONTO, Sept. 23, 2013 /CNW/ - Bayer Inc. announced today the Health Canada approval of Adempas® (riociguat). Adempas® is the first drug...

2013-09-20 00:20:36

Patients encouraged to embrace digital advances which allow "networking to a degree that previously might not have been possible" BRISBANE, Calif., Sept. 20, 2013 /PRNewswire/ -- This year's IPF World Week (September 21-29) sees healthcare professionals, patient advocacy groups, people living with idiopathic pulmonary fibrosis (IPF), who have an estimated median survival time of two to five years,(i )and their families calling for an integrated approach to further strengthen the...

2013-09-17 08:31:07

REHOVOT, Israel, September 17, 2013 /PRNewswire/ -- Israeli biomed company AIT (Advanced Inhalation Therapies Ltd.), a leader in the development of nitric oxide therapeutics for the treatment of infectious respiratory diseases, announced today the appointment of Hugh M. O'Brodovich, M.D.,to its scientific advisory board. Dr. O'Brodovich holds the position of Arline & Pete Harman Professor & Chair at the Department of Pediatrics Stanford School of Medicine. Dr....

2013-09-10 16:24:41

New Phase 3 data presented for the first time at the European Respiratory Society (ERS) Annual Congress 2013 RIDGEFIELD, Conn., Sept. 10, 2013 /PRNewswire/ -- Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma(®) program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma(®) Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the...

2013-09-10 14:12:14

A doctor from the UK has shown how an innovative music video can help increase awareness of how to treat asthma. Dr Tapas Mukherjee, from Glenfield Hospital in the UK, produced and starred in a music video to draw attention to new guidelines showing a better way of managing asthma. A study presented at the European Respiratory Society (ERS) Annual Congress in Barcelona today (10 September 2013), has demonstrated the success of this video and suggests that social media can be used to...

2013-09-09 16:24:20

ATLANTA, Sept. 9, 2013 /PRNewswire/ -- Celtaxsys, Inc., an Atlanta-based pharmaceutical discovery and development company, announced today that it has restructured its management and operations to focus on development of its lead clinical stage drug candidate, CTX-4430, for treatment of Cystic Fibrosis (CF) lung disease. As part of the restructuring, Dr. Michael Hanley has retired from his role as CEO and Chairman, and Dr. Brett Premack has stepped down as CTO. Dr. H. Daniel Perez,...


Latest Pulmonology Reference Libraries

0_f9fe10c6664d20ba0d9091907b66a65f
2011-01-05 16:00:36

Human parainfluenza viruses, belonging to the paramyxovirus family, are a group of four distinct serotypes of enveloped single-stranded RNA viruses. They are the second most common cause of lower respiratory tract infection in younger children. Many times the host has repeat infections throughout life with symptoms that may include upper respiratory tract illness or more commonly, a cold and sore throat. It can also cause severe pneumonia in immunosuppressed people. There is currently no...

More Articles (1 articles) »